1. 21PBaseline total metabolic tumor volume assessed by 18FDG-PET/CT predicts outcome in advanced melanoma patients treated with pembrolizumab. (17th December 2018) Authors: Awada, G; Özdemir, I; Schwarze, J K; Daeninck, E; Gondry, O; Jansen, Y; Seremet, T; Keyaerts, M; Everaert, H; Neyns, B Journal: Annals of oncology Issue: Volume 29(2018)Supplement 10 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 34P Development of LAG-3 nanobodies as potent cancer imaging tracers. (15th December 2019) Authors: Lecocq, Q; Awad, R M; Zeven, K; Vlaeminck, Y De; de Mey, W; Debie, P; Puttemans, J; Goyvaerts, C; Raes, G; Keyaerts, M; Devoogdt, N; Breckpot, K Journal: Annals of oncology Issue: Volume 30(2019)Supplement 11 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 85TiPPhase II trial of HER2-PET/CT using 68Ga-anti-HER2 VHH1 for characterization of HER2 presence in brain metastases of breast cancer patients. (13th May 2019) Authors: Keyaerts, M; Xavier, C; Everaert, H; Vaneycken, I; Fontaine, C; Decoster, L; Vanhoeij, M; Caveliers, V; Lahoutte, T Journal: Annals of oncology Issue: Volume 30(2019)Supplement 3 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗